CB1 is localized presynaptically and regulates neurotransmitter release, indicating potential contributions of hippocampal CB1 deficits and compensation to excitatory-inhibitory neuronal imbalance in AD 23-26, and the therapeutic potential of the ECS. Here, CNR1 is linked to Alzheimer disease.